Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
Xiaoting Zhou, Yanghong Ni, Xiao Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
Shovan Dutta, Anirban Ganguly, Kaushiki Chatterjee, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 218-218
Open Access | Times Cited: 71
Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance
Mahboubeh Tajaldini, Amirhoushang Poorkhani, Taghi Amiriani, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 175991-175991
Closed Access | Times Cited: 22
Imaging immune checkpoint networks in cancer tissues with supermultiplexed SERS nanoprobes
Jin Li, Fugang Liu, Xinyuan Bi, et al.
Biomaterials (2023) Vol. 302, pp. 122327-122327
Closed Access | Times Cited: 22
Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies
Nating Xiong, Heming Wu, Zhikang Yu
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 12
Dendritic Cells in Shaping Anti-Tumor T Cell Response
Luciano Mazzoccoli, Bei Liu
Cancers (2024) Vol. 16, Iss. 12, pp. 2211-2211
Open Access | Times Cited: 9
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models
Gonzalo Rodríguez‐Berriguete, Rathi Puliyadi, Nicole Machado, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Anticancer potential of garlic bioactive constituents: Allicin, Z-ajoene, and organosulfur compounds
Wamidh H. Talib, Sally Atawneh, Areen Nabil Shakhatreh, et al.
Pharmacia (2024) Vol. 71, pp. 1-23
Open Access | Times Cited: 6
PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD‐1 blockade
Wout De Wispelaere, Daniela Annibali, Sandra Tuyaerts, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 5
Open Access | Times Cited: 6
OrganoIDNet: a deep learning tool for identification of therapeutic effects in PDAC organoid-PBMC co-cultures from time-resolved imaging data
Nathalia Ferreira, Ajinkya Kulkarni, David Agorku, et al.
Cellular Oncology (2024)
Open Access | Times Cited: 5
Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access
Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
Masaud Shah, Muhammad Hussain, Hyun Goo Woo
Genomics & Informatics (2025) Vol. 23, Iss. 1
Open Access
Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects
Zahid Rafiq, M.J. Kang, Hampartsoum B. Barsoumian, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Hierarchical Protein Nano-crystalline Hydrogel with Extracellular Vesicles for Ectopic Lymphoid Structure Formation
Wooin Ahn, Ji-Hoon Han, Nayeon Kim, et al.
Biomaterials (2025) Vol. 318, pp. 123166-123166
Closed Access
Development of a prognostic model based on the ceRNA network in Triple-Negative Breast cancer
Yimin Zhu, Jiayu Wang, Binghe Xu
PeerJ (2025) Vol. 13, pp. e19063-e19063
Open Access
Current Progress and Future Directions of Immunotherapy in Head and Neck Squamous Cell Carcinoma
Edward S. Sim, Hoang C.B. Nguyen, Glenn J. Hanna, et al.
JAMA Otolaryngology–Head & Neck Surgery (2025)
Closed Access
Efficacy and safety of postoperative adjuvant HAIC with FOLFOX combining PD-1 inhibitors in HCC patients with microvascular invasion: a propensity score matching analysis
Yuxin Liang, Deyuan Zhong, Jin Shang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
The Dual Role of Chaperone-mediated Autophagy in the Response and Resistance to Cancer Immunotherapy
Mohammadreza Saberiyan, Sarah Gholami, Mahsa Ejlalidiz, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104700-104700
Open Access
Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
Fuat Bicer, Catrina Kure, Anil A. Ozluk, et al.
Current Oncology (2023) Vol. 30, Iss. 11, pp. 9789-9812
Open Access | Times Cited: 14
The recent advancement of TCR-T cell therapies for cancer treatment
Xiang Zhao, Shuai Shao, Lanxin Hu
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 4
Inorganic Nanoparticle Functionalization Strategies in Immunotherapeutic Applications
Wei Mao, Hyuk Sang Yoo
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 4
Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies
Piero Giuseppe Meliante, Christian Barbato, Federica Zoccali, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15384-15384
Open Access | Times Cited: 15
Tissue biomarkers of immune checkpoint inhibitor therapy
Fatemeh Davoudi, Afshin Moradi, Habib Sadeghirad, et al.
Immunology and Cell Biology (2024) Vol. 102, Iss. 3, pp. 179-193
Open Access | Times Cited: 2
Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology Research
Laura Chambers, Paulina Haight, Julia Chalif, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 14, pp. 2905-2909
Closed Access | Times Cited: 2
Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy
Kewen He, Nahum Puebla‐Osorio, Hampartsoum B. Barsoumian, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top